These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 23479988)
1. [Efficacy of ceruloplasmin in patients with asthma]. Farkhutdinov UR; Farkhutdinov ShU Ter Arkh; 2012; 84(12):45-8. PubMed ID: 23479988 [TBL] [Abstract][Full Text] [Related]
2. Omalizumab in patients with severe asthma: the XCLUSIVE study. Schumann C; Kropf C; Wibmer T; Rüdiger S; Stoiber KM; Thielen A; Rottbauer W; Kroegel C Clin Respir J; 2012 Oct; 6(4):215-27. PubMed ID: 21740532 [TBL] [Abstract][Full Text] [Related]
3. [Effects of combined therapy with domestic inhalational anti-asthmatic drugs on oxidant status of patients with bronchial asthma]. Kolpakova AF Ter Arkh; 2007; 79(3):41-4. PubMed ID: 17526195 [TBL] [Abstract][Full Text] [Related]
4. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC; Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493 [TBL] [Abstract][Full Text] [Related]
5. [Intravascular laser irradiation of blood in the treatment of patients with bronchial asthma]. Farkhutdinov UR Ter Arkh; 2007; 79(3):44-8. PubMed ID: 17526196 [TBL] [Abstract][Full Text] [Related]
6. [Effect of mucolytic therapy on the production of reactive oxygen species in the blood of patients with an exacerbation of chronic obstructive pulmonary disease]. Farkhutdinov UR; Farkhutdinov RR; Petriakov VV; Farkhutdinov ShU; Mirkhaĭdarov AM Ter Arkh; 2010; 82(3):29-32. PubMed ID: 20564918 [TBL] [Abstract][Full Text] [Related]
7. [A clinical study on the significance of airway hyperresponsiveness monitoring in the adjustment of combined therapy for asthmatic patients]. Liu CT; Wang YM; Wang G; Tan CW; Pang YM Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jul; 30(7):498-503. PubMed ID: 17961403 [TBL] [Abstract][Full Text] [Related]
8. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715 [TBL] [Abstract][Full Text] [Related]
9. Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study. Koutsoubari I; Papaevangelou V; Konstantinou GN; Makrinioti H; Xepapadaki P; Kafetzis D; Papadopoulos NG Pediatr Allergy Immunol; 2012 Jun; 23(4):385-90. PubMed ID: 22433020 [TBL] [Abstract][Full Text] [Related]
10. [Enterosorption in complex therapy of bronchial asthma]. Farkhutdinov UR Klin Med (Mosk); 2005; 83(4):31-4. PubMed ID: 15941139 [TBL] [Abstract][Full Text] [Related]
12. Asthma management and asthma control in São Paulo, Brazil and Uppsala, Sweden: a questionnaire-based comparison. Skorup P; Rizzo LV; Machado-Boman L; Janson C Clin Respir J; 2009 Jan; 3(1):22-8. PubMed ID: 20298368 [TBL] [Abstract][Full Text] [Related]
13. Increased oxygen species generation in blood monocytes of asthmatic patients. Vachier I; Damon M; Le Doucen C; de Paulet AC; Chanez P; Michel FB; Godard P Am Rev Respir Dis; 1992 Nov; 146(5 Pt 1):1161-6. PubMed ID: 1443865 [TBL] [Abstract][Full Text] [Related]
14. Improvement of asthma therapy by a novel budesonide multidose dry powder inhaler. Möller M; Fritsche D; Rivera D; Libertus H Arzneimittelforschung; 2003; 53(8):562-7. PubMed ID: 13677246 [TBL] [Abstract][Full Text] [Related]
15. Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations. Matz J; Emmett A; Rickard K; Kalberg C J Allergy Clin Immunol; 2001 May; 107(5):783-9. PubMed ID: 11344343 [TBL] [Abstract][Full Text] [Related]
16. Outcome measures and serious asthma exacerbation in clinical trials of asthma controller medications. Schilling JP; Khan SR; Khan A Ann Allergy Asthma Immunol; 2012 Jun; 108(6):448-53. PubMed ID: 22626599 [TBL] [Abstract][Full Text] [Related]
17. Treatment and evaluation of patients with acute exacerbation of asthma before and during a visit to the ER in Denmark. Backer V; Harving H; Søes-Petersen U; Ulrik CS; Plaschke P; Lange P Clin Respir J; 2008 Jan; 2(1):54-9. PubMed ID: 20298305 [TBL] [Abstract][Full Text] [Related]
18. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212 [TBL] [Abstract][Full Text] [Related]
19. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma. Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218 [TBL] [Abstract][Full Text] [Related]
20. Clinical benefits of 7 years of treatment with omalizumab in severe uncontrolled asthmatics. Pace E; Ferraro M; Bruno A; Chiappara G; Bousquet J; Gjomarkaj M J Asthma; 2011 May; 48(4):387-92. PubMed ID: 21391878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]